SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Johnson & Johnson to Acquire Ollin Biosciences for USD 2.2bn

Johnson & Johnson has agreed to acquire US-based Ollin Biosciences.

JNJ

Related stories